Fingerprint
Dive into the research topics of 'Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases
G. R. Burmester, P. Mease, B. A.C. Dijkmans, K. Gordon, D. Lovell, R. Panaccione, J. Perez, A. L. Pangan
Research output: Contribution to journal › Article › peer-review
170
Scopus
citations